Thiamine for prevention and treatment of Wernicke-Korsakoff Syndrome in people who abuse alcohol

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 7, 2013, Pages

  Day, Ed ^a   Bentham, Peter W ^a   Callaghan, Rhiannon ^b   Kuruvilla, Tarun ^c   George, Sanju ^a  

^a BIRMINGHAM AND SOLIHULL MENTAL HEALTH NHS FOUNDATION TRUST   (United Kingdom)

^b St Davids Hospital   (United Kingdom)

^c Gloucestershire Health and Care NHS Foundation Trust   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIAZEPAM; PABRINEX; PLACEBO; THIAMINE;

ALCOHOL ABUSE; ATAXIA; COGNITIVE DEFECT; CONFIDENCE INTERVAL; DRUG EFFICACY; HUMAN; NYSTAGMUS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT OUTCOME; WERNICKE KORSAKOFF SYNDROME; KORSAKOFF SYNDROME; KORSAKOFF PSYCHOSIS;

HUMANS; KORSAKOFF SYNDROME; RANDOMIZED CONTROLLED TRIALS AS TOPIC; THIAMINE;

EID: 84891639324     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD004033.pub3     Document Type: Review

References (31)

1. Ambrose ML, Bowden SC, Whelan G. Thiamin treatment and working memory function of alcohol-dependent people: preliminary findings. Alcoholism Clinical and Experimental Research 2001; Vol. 25, issue 1:112-6.
2. Nichols ME, Meador KJ, Loring DW, Moore EE. Preliminary findings on the clinical effects of high dose thiamine in alcohol-related cognitive disorders. No source no year.
3. Peters TJ, Kotowicz J, Nyka W, Kozubski W, Kuznetsov V, Vanderbist F, et al. Treatment of alcoholic polyneuropathy with vitamin B complex: a randomised controlled trial. Alcohol and Alcoholism 2006;41(6):636-42.
4. Becker JT, Furman JMR, Panisset M, Smith C. Characteristics of the memory loss of a patient with Wernicke-Korsakoff's syndrome without alcoholism. Neuropsychologia 1990;28(2):171-9.
5. Bowden SC. Separating cognitive impairment in neurologically asymptomatic alcoholism from Wernicke-Korsakoff syndrome: is the neuropsychological distinction justified?. Psychological Bulletin 1990;107(3):355-66.
6. Butterworth RF, Kril JJ, Harper CG. Thiamine-dependent enzyme changes in the brains of alcoholics: relationship to the Wernicke-Korsakoff syndrome. Alcoholism: Clinical and Experimental Research 1993;17:1084-8.
7. Caine D, Halliday GM, Kril JJ, Harper CG. Operational criteria for the classification of chronic alcoholics: identification of Wernicke's encephalopathy. Journal of Neurology, Neurosurgery, and Psychiatry 1997;62:51-60.
8. Cook CC, Hallwood PM, Thomson AD. B vitamin deficiency and neuropsychiatric syndromes in alcohol misuse. Alcohol and Alcoholism 1998;33:317-36.
9. Cook CCH. Prevention and treatment of Wernicke-Korsakoff syndrome. Alcohol and Alcoholism 2000;35(Suppl 1):19-20.
10. Freedman M, Oscar-Berman M. Bilateral frontal lobe disease and selective delayed response deficits in humans. Behavioral Neurosciences 1986;100:337-42.
11. Greb A, Bitsch R. Comparative bioavailability of various thiamine derivatives after oral administration. International Journal of Clinical Pharmacology and Therapeutics 36;4:216-21.
12. Harper C. Wernicke's encephalopathy: a more common disease than realised. Journal of Neurology, Neurosurgery, and Psychiatry 1979;42:226-31.
13. Harper CG, Giles M, Finlay-Jones R. Clinical signs in the Wernicke-Korsakoff complex: a retrospective analysis of 131 cases diagnosed at necropsy. Journal of Neurology, Neurosurgery, and Psychiatry 1986;49:341-5.
14. Harper C, Fornes P, Duyckaerts C, Lecomte D, Hauw J-J. An international perspective on the prevalence of the Wernicke-Korsakoff syndrome. Metabolic Brain Disease 1995;10:17-24.
15. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane-handbook.org.
16. Lishman WA. Wernicke's encephalopathy. Organic Psychiatry. The Psychological Consequences of Cerebral Disorder. 3rd Edition. Oxford: Blackwell Science, 1998:575-85.
17. McLean J, Manchip S. Wernicke's encephalopathy induced by magnesium depletion. Lancet 1999;353:1768.
18. National Clinical Guideline Centre for Acute and Chronic Conditions. Clinical Guideline 100. London: Royal College of Physicians, 2010.
19. Phillips GB, Victor M, Adams RD, Davidson CS. A study of the nutritional defect in Wernicke's syndrome. Journal of Clinical Investigation 1952;31:859-71.
20. Ramayya A, Jauhar P. Increasing incidence of Korsakoff's psychosis in the East End of Glasgow. Alcohol and Alcoholism 1997;32:281-5.
21. Sechi G, Serra A. Wernicke's encephalopathy: new clinical settings and recent advances in diagnosis and management. Lancet Neurology 2007;6:442-55.
22. Thomson AD, Jeuasingham M, Pratt OE. Nutrition and alcoholic encephalopathies. Acta Medica Scandinavica 1987;717(Suppl):55-65.
23. Thomson AD, Cook CCH. Parenteral thiamine and Wernicke's encephalopathy: the balance of risks and perception of concern. Alcohol and Alcoholism 1997;32(3):207-9.
24. Thomson AD, Marshall EJ. The treatment of patients at risk of developing Wernicke's encephalopathy in the community. Alcohol & Alcoholism 2006;41(2):159-67.
25. Thomson AD, Cook CCH, Guerrini I, Sheedy D, Harper C, Marshall EJ. Wernicke's encephalopathy: 'Plus ca cange, plus c'est la meme chose'. Alcohol & Alcoholism 2008;43:180-6.
26. Thomson AD, Guerrini I, Marshall EJ. The evolution and treatment of Korsakoff's syndrome: out of sight, out of mind?. Neuropsychology Review 2012;22:81-92.
27. Torvik A. Wernicke's encephalopathy-prevalence and clinical spectrum. Alcohol and Alcoholism 1991;(Suppl 1):381-4.
28. Victor M, Adams RD, Collins GH. The Wernicke-Korsakoff Syndrome. Philadelphia: F. A. Davis Company, 1971.
29. Victor M, Adams RD, Collins GH. The Wernicke-Korsakoff Syndrome and Related Neurological Disorders Due to Alcoholism and Malnutrition. Philadelphia: F. A. Davis Company, 1989.
30. Wood B, Currie J. Presentation of acute Wernicke's encephalopathy and treatment with thiamine. Metabolic Brain Disease 1995;10(1):57-72.
31. Day E, Bentham P, Callaghan R, Kuruvilla T, George S. Thiamine for Wernicke-Korsakoff syndrome in people at risk from alcohol abuse. Cochrane Database of Systematic Reviews 2004, Issue 1. [DOI: 10.1002/14651858.CD004033.pub2]